Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
preclinical research
Biotech
Biogen discontinues all AAV gene therapy work
While most of the team members that had focused on AAV capsids were reassigned to other roles, a small number of employees were laid off.
Gabrielle Masson
Sep 26, 2025 11:04am
Rome nears end of road with planned layoffs, strategic review
Sep 23, 2025 2:00pm
Chinese CRO ChemPartner gets ready to debut US research facility
Aug 26, 2025 2:57pm
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm
GSK and Oxford University ink cancer vaccine research pact
Jan 26, 2025 7:01pm
Biogen shrinks research team, prioritizes external innovation
Jan 22, 2025 4:10pm
